EU approves use of Stevia in food and beverages
Evolva is rapidly advancing the development of highly purified forms of the natural high intensity sweetener Stevia, produced via fermentation in yeast. Evolva's research team has already successfully made the important individual steviol glycoside components of Stevia via fermentation in yeast. Evolva believes the ability to produce such molecules individually has significant market potential by allowing cost effective production of the best tasting steviol glycosides, including those found at very low levels in the Sevia leaf. This will allow our customers the ability to better customise taste profiles. Over the next year, the focus will be on optimising the production host and associated manufacturing conditions.
Neil Goldsmith, CEO and Managing Director of Evolva, commented: “This is important news for Evolva. It confirms and expands the potential of our Stevia-pipeline. We are working hard to develop Stevia compounds, equivalent to the plant-derived product, but made via fermentation in yeast. This approach confers major additional benefits in the form of a more reliable and scalable supply-chain, a better and more customisable taste profile and more attractive pricing. Combined these benefits will allow many more people around the world to enjoy the benefits that are inherent to Stevia.”
Most read news
Other news from the department politics & laws
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.